Immune cells from your tumor for advanced melanoma
Part of Cancer, Skin clinical trials.
This study tests a new type of cell therapy made from your own immune cells (called TILs) to see if it can shrink tumors better than standard chemotherapy in people with advanced melanoma that has stopped responding to immunotherapy. If you qualify, you may have a chance to try a personalized treatment that uses your body's own defenses to fight the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- Your melanoma must be advanced, recurrent, or have spread (not the eye type, uveal melanoma), and have gotten worse after standard treatments.
- Your cancer must have progressed after treatment with an anti-PD-1 drug like Keytruda or Opdivo.
- You need a tumor sample (at least the size of a small pea) that can be removed for making the treatment.
- You must be in good enough health to undergo surgery and receive the study treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes). The cells are taken from a tumor sample, multiplied in a lab, and given back to you to help fight the cancer. It's for people with melanoma that has not responded to standard immunotherapy.
This early-phase trial tests GC101 TIL, a treatment made from your own melanoma tumor cells, for advanced melanoma. It may help the immune system better fight the cancer after standard treatments have already stopped working or if none are available.
This trial tests a new T-cell therapy made from your own tumor (TILs), genetically edited to remove the PD1 checkpoint blocker. It may help your immune system fight melanoma that has not responded to standard treatments like anti-PD1 therapy.
This trial tests a treatment using your own immune cells to fight advanced melanoma. The cells are taken from a tumor, grown in a lab, and given back to you either near the tumor or throughout your body.
This trial tests a treatment that uses your own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight melanoma. Some participants also get a drug called pembrolizumab. The goal is to see if this approach can shrink tumors.
This trial tests a treatment called tumor-infiltrating lymphocyte (TIL) therapy for people with advanced melanoma that has not responded to immune checkpoint inhibitors. TIL therapy uses your own immune cells to fight the cancer. The study aims to see if this can help shrink tumors or slow the disease.
Hear when a new Melanoma (Excluding Uveal Melanoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.